BG Medicine: Scientific Article Outlines Role of Galectin-3 in Heart Failure Development and Progression

Published: Aug 06, 2009

WALTHAM, Mass.--(BUSINESS WIRE)--BG Medicine, Inc., a discovery-based diagnostic company, today announced the publication of a peer-reviewed article on the role of galectin-3 in heart failure development and progression. The article, which was authored by Dr. Rudolph de Boer, et.al., from the University Medical Center Groningen, The Netherlands, appeared in the European Journal of Heart Failure (see below for full citation). The abstract, and instructions on how to obtain the full article, can be found at www.galectin-3.com.

Back to news